Patients may now avail of molnupiravir, an antiviral drug for the treatment of mild to moderate cases of coronavirus disease (COVID-19), under the Office of the Vice President’s (OVP) Bayanihan E-Konsulta program. The good news announced by Vice President Leni Robredo on Monday night, Nov. 22,...
Ayala Corporation announced that the first shipment of Molnupiravir, an oral anti-viral treatment for mild COVID-19, arrived in the country through a partnership between MedEthix, a member of the Ayala Healthcare Holdings, Inc. (AC Health). MedEthix, one of the country’s major pharmaceutical...
Molnupiravir (AFP / MANILA BULLETIN) The first batch of supplies of COVID-19 oral antiviral drug Molnupiravir will arrive in the Philippines on Thursday, Nov. 18. This was announced by Faberco Life Sciences Inc. on Wednesday, Nov. 17. The Molnupiravir drug was developed by Merck & Co, Inc....
Experimental oral coronavirus disease (COVID-19) antiviral drug, M olnupiravir, is said to be effective against known variants of the virus, including the highly transmissible Delta variant, and reduce the risk of hospitalization for patients. Molnupiravir (AFP / MANILA BULLETIN) In a recent...
Medicines (File Photo) The price of the new antiviral drug molnupiravir, a potential treatment for COVID-19, will not be that expensive and will be accessible to the people, a local official of MSD Pharmaceuticals said. MSD Philippines President and Managing Director Dr. Beaver Tamesis made the...
The procurement of Molnupiravir, an anti-viral pill that its developer Merck & Co.boasts as a potential game changer in the fight against COVID-19, will have to be considered in amending the proposed 2022 national budget. Rep. Joey Sarte Salceda Albay Rep. Joey Sarte-Salceda aired this...
Medicines (File Photo) The Department of Health (DOH) said it is closely monitoring the latest development in the ongoing clinical trials of Molnupiravir, which could be the first oral antiviral medication for coronavirus disease (COVID-19). DOH Undersecretary Maria Rosario Vergeire said that they...
Medicines (File Photo) The Lung Center of the Philippines (LCP) and the Quirino Memorial Medical Center (QMMC) are encouraging coronavirus disease (COVID-19) patients to participate in the clinical trial to test the effectiveness of antiviral drug Molnupiravir in the treatment of the said...
The antiviral drug, “Molnupiravir" as treatment for mild and moderate coronavirus disease (COVID-19) cases is now on Phase 3 clinical trial at the Lung Center of the Philippines. (Facebook/MANILA BULLETIN FILE PHOTO) The clinical trial started on May 17 this year and has enrolled a total of 11...
